A convenient extension of the Wessely-Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 8, 2000, Pages 835-838

  Larget, Ronan ^a   Lockhart, Brian ^b   Renard, Pierre ^c   Largeron, Martine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c ADIR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 ALKYLAMINO 5,7 DIHYDROXYFLAVONE; CHRYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHEMICAL MODIFICATION; HIPPOCAMPUS; IN VITRO STUDY; ISOMER; MOUSE; NEUROPROTECTION; NONHUMAN;

FLAVONOIDS; NEUROPROTECTIVE AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0034678787     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00110-4     Document Type: Article

References (25)

1. Halliwell, B.; Gutteridge, J. M. C. In Free Radicals in Biology and Medicine, 3rd ed.; Oxford University Press, Oxford, 1999; pp 246-350.
2. Fleury, M.-B.; Maurette, J.-M.; Largeron, M. PCT Int. Appl. WO 95 18114/1995 (Chem. Abstr. 1995, 123, 340 160x).
3. Largeron M., Dupuy H., Fleury M.-B. Tetrahedron. 51:1995;4953.
4. Largeron M., Fleury M.-B. Tetrahedron Lett. 39:1998;8999.
5. Largeron M., Neudorffer A., Fleury M.-B. Tetrahedron Lett. 39:1998;5035.
6. Larget R., Lockhart B., Pfeiffer B., Fleury M.-B., Largeron M. Bioorg. Med. Chem. Lett. 9:1999;2929.
7. Largeron M., Lockhart B., Pfeiffer B., Fleury M.-B. J. Med. Chem. 42:1999;5043.
8. Fleury, M.-B.; Largeron, M.; Lestage, P.; Lockhart, B. ADIR and Cie Fr. Patent Appl. 9806809 May 29, 1998; PCT/FR 99/01254, May 28, 1999.
9. Bors W., Saran M. Free Radical Res. Commun. 2:1987;289.
10. Cotelle N., Bernier J.-L., Catteau J.-P., Pommery J., Wallet J.-C., Gaydou E.-M. Free Radical Biol. Med. 20:1996;35.
11. Gao D., Tawa R., Masaki H., Okano Y., Sakurai H. Chem. Pharm. Bull. 46:1998;1383.
12. Baker, W. J. Chem. Soc. 1933, 1381.
13. Iinuma M., Tanaka T., Mizuno M. Chem. Pharm. Bull. 35:1987;660.
14. Le Floc'h Y., Lefeuvre M. Tetrahedron Lett. 27:1986;2751.
15. Cushman M., Nagarathnam D. Tetrahedron Lett. 31:1990;6497.
16. Saxena, S.; Makrandi, J. K.; Grover, S. K. Synthesis 1985, 697.
17. Wessely F., Moser G.H. Monatsh. Chem. 56:1930;97.
18. Bellamy F.D., Ou K. Tetrahedron Lett. 25:1984;839.
19. Fukuyama T., Cheung M., Jow C.K., Hidai Y., Kan T. Tetrahedron Lett. 38:1997;5831.
20. Mitsunobu, O. Synthesis 1981, 1.
21. Philbin, E. M.; Swirski, J.; Wheeler, T. S. J. Chem. Soc. 1956, 4455 and references cited therein.
22. Seshadri, T. R. Tetrahedron 1959, 6, 169 and references cited therein.
23. Shaw S.C., Azad R., Mandal S.P., Gandri R.S. J. Indian Chem. Soc. 65:1988;107.
24. +).
25. In vitro biological assays are extensively detailed in refs 6 and 7.